ASX:VITPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
VITURA HEALTH ORD
$0.037
$0.002 (5.13%)
Day Range
$0.037 - $0.039
52 Week Range
$0.035 - $0.075
Volume
153.85K
Avg Volume (10D)
366.64K
Market Cap
$24.52M
P/E Ratio
6.97
Price Chart
Market Statistics
Open$0.039
Previous Close$0.039
Day High$0.039
Day Low$0.037
52 Week High$0.075
52 Week Low$0.035
Valuation
Market Cap24.52M
Shares Outstanding662.74M
P/E Ratio (Annual)6.97
P/E Ratio (TTM)31.93
Dividend Yield5.26%
Price to Book0.55
Trading Activity
Volume153.85K
Value Traded5.72K
Bid$0.037 × 81,370
Ask$0.038 × 361,578
Performance
1 Day-2.56%
5 Day5.56%
13 Week-33.33%
52 Week-47.22%
YTD-37.70%
Technical Indicators
RSI (14)44.66
50-Day SMA$0.040
200-Day SMA$0.058
Latest News
Biotechnology
Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million
VIT hits profitability: Doctors on Demand tops 1 million consultations since FY2024; revenue rises 54% to FY2026 Q1-Q3, EBITDA positive at 5%.
2 min read
Industrials & Juniors
Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products
Vitura Health strikes MedReleaf distribution deal, targeting up to $15m extra annual revenue via Canview across 4,700 pharmacies.
1 min read
Hot TopicsIndustrials & Juniors
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]
2 min read
